ACLARIS THERAPEUTICS INC's ticker is ACRS and the CUSIP is 00461U105. A total of 100 filers reported holding ACLARIS THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.65 and the average weighting 1.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $315,487 | +28.8% | 30,423 | +123.4% | 0.00% | 0.0% |
Q3 2021 | $245,000 | -73.5% | 13,619 | -62.8% | 0.00% | -75.0% |
Q1 2021 | $923,000 | +348.1% | 36,612 | +6.2% | 0.00% | +300.0% |
Q1 2019 | $206,000 | -98.4% | 34,490 | -92.6% | 0.00% | -98.8% |
Q4 2016 | $12,667,000 | +309.4% | 466,734 | +286.4% | 0.08% | +277.3% |
Q3 2016 | $3,094,000 | – | 120,800 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Foresite Capital Management V, LLC | 1,258,243 | $8,618,965 | 13.75% |
Foresite Capital Management IV, LLC | 2,808,034 | $19,235,033 | 10.68% |
Bain Capital Life Sciences Investors, LLC | 3,400,000 | $23,290,000 | 2.60% |
GREAT POINT PARTNERS LLC | 1,691,768 | $11,588,611 | 2.11% |
Samsara BioCapital, LLC | 696,171 | $4,768,771 | 1.46% |
Altium Capital Management LP | 403,000 | $2,760,550 | 1.44% |
BVF INC/IL | 7,064,736 | $48,393,442 | 1.30% |
Aisling Capital Management LP | 434,455 | $2,976,017 | 1.23% |
GREAT POINT PARTNERS LLC | 700,000 | $4,795,000 | 0.87% |
VR Adviser, LLC | 1,040,754 | $7,129,165 | 0.75% |